Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
NCT ID: NCT02242669
Last Updated: 2017-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
371 participants
OBSERVATIONAL
2014-11-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peer Support for Severe Mental Disorders
NCT02276469
Trial of a Positive Psychology Intervention in Major Depressive Disorder
NCT02004145
Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities
NCT05336955
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
NCT02151331
Resiliency Training on the College Campus
NCT06038786
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AIM 1
200 current DBSA participants.
No interventions assigned to this group
AIM 2
60 new DBSA attendees with mood disorders who have attended their first meeting in the past month.
No interventions assigned to this group
AIM 3
100 matched control group individuals with mood disorders with no current or prior exposure to DBSA.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Self-report a diagnosis of any type of mood disorder
* Attend DBSA meetings
* Aim 2:
* 18 years of age or older
* Self-report a diagnosis of any type of mood disorder
* Have attended their first meeting in the past month
* Aim 3:
* 18 years of age or older
* Self-report a diagnosis of any type of mood disorder
* Have never attended a DBSA meeting
Exclusion Criteria
* Do not report a diagnosis of any type of mood disorder
* Have not attended a DBSA meeting
* Aim 2:
* Do not report a diagnosis of any type of mood disorder
* Have not attended a DBSA meeting
* Have attended their first meeting prior to a month before their assessment
* Aim 3:
* Do not report a diagnosis of any type of mood disorder
* Have attended a DBSA meeting
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John F. Kelly
Associate Professor of Psychiatry Harvard Medical School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John F Kelly, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McLean Hospital
Belmont, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014P000153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.